Loading...
XJPX4694
Market cap690mUSD
Jan 14, Last price  
2,783.00JPY
1D
-1.31%
1Q
3.38%
Jan 2017
-0.11%
Name

BML Inc

Chart & Performance

D1W1MN
XJPX:4694 chart
P/E
17.99
P/S
0.79
EPS
154.69
Div Yield, %
3.59%
Shrs. gr., 5y
-1.77%
Rev. gr., 5y
3.33%
Revenues
137.96b
-13.48%
67,705,499,00070,712,565,00071,834,307,00072,832,496,00077,198,713,00079,259,997,00080,762,000,00092,201,000,00094,608,000,00099,047,000,000104,404,000,000109,024,000,000111,243,000,000113,502,000,000117,129,000,000120,732,000,000138,571,000,000186,067,000,000159,462,000,000137,964,000,000
Net income
6.03b
-61.27%
1,717,579,0001,972,454,0002,085,793,0002,373,831,0003,075,220,0003,550,233,0003,594,000,0002,392,000,0003,708,000,0004,990,000,0003,874,000,0005,424,000,0005,948,000,0005,988,000,0006,646,000,0006,375,000,00013,711,000,00033,741,000,00015,578,000,0006,034,000,000
CFO
14.45b
+23.03%
5,769,061,0007,422,525,0005,320,690,0006,397,100,0007,717,551,0009,388,279,0008,683,000,0008,092,000,0009,792,000,00010,931,000,00011,495,000,00011,978,000,00011,307,000,00012,079,000,00012,507,000,00012,771,000,00019,574,000,00045,603,000,00011,742,000,00014,446,000,000
Dividend
Mar 28, 20250 JPY/sh

Profile

BML, Inc. provides laboratory testing and related services in Japan. The company offers general laboratory tests, including biochemical and hematologic examinations; special laboratory tests, such as RIA, cellular, immunological, and DNA analysis; microbiological tests for medical and pharmaceutical societies and organizations; and laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies. It also develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures; and provides electronic medical charts for networking medical information, as well as offers preventive medicine services. In addition, the company provides food sanitation control and food processing services comprising contract services for microorganism testing of raw materials, and prepared and processed foods; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and waste water tests; work sanitation management services, such as measurement of ethylene oxide gas, formaldehyde, organic solvents, and dust; environmental monitoring services, including measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; and gene expression analysis and testing for genes that cause susceptibility to infectious diseases. BML, Inc. was founded in 1955 and is headquartered in Tokyo, Japan.
URL
https://www.bml.co.jp/
IPO date
Apr 25, 2001
Employees
4,415
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
137,964,000
-13.48%
159,462,000
-14.30%
186,067,000
34.28%
Cost of revenue
92,610,000
98,287,000
99,418,000
Unusual Expense (Income)
NOPBT
45,354,000
61,175,000
86,649,000
NOPBT Margin
32.87%
38.36%
46.57%
Operating Taxes
3,260,000
8,027,000
15,650,000
Tax Rate
7.19%
13.12%
18.06%
NOPAT
42,094,000
53,148,000
70,999,000
Net income
6,034,000
-61.27%
15,578,000
-53.83%
33,741,000
146.09%
Dividends
(3,900,000)
(4,964,000)
(3,455,000)
Dividend yield
3.44%
4.09%
2.76%
Proceeds from repurchase of equity
423,000
(3,440,000)
BB yield
-0.35%
2.75%
Debt
Debt current
1,533,000
1,363,000
1,194,000
Long-term debt
8,997,000
6,937,000
5,466,000
Deferred revenue
(331,000)
(395,000)
Other long-term liabilities
2,474,000
4,025,000
3,361,000
Net debt
(66,686,000)
(82,536,000)
(88,719,000)
Cash flow
Cash from operating activities
14,446,000
11,742,000
45,603,000
CAPEX
(20,927,000)
(6,460,000)
(7,085,000)
Cash from investing activities
(21,137,000)
(7,627,000)
(7,297,000)
Cash from financing activities
(5,733,000)
(9,715,000)
(9,828,000)
FCF
26,357,000
47,999,000
69,347,000
Balance
Cash
74,114,000
86,521,000
92,126,000
Long term investments
3,102,000
4,315,000
3,253,000
Excess cash
70,317,800
82,862,900
86,075,650
Stockholders' equity
130,048,000
251,171,000
238,184,000
Invested Capital
67,558,200
51,120,100
29,301,350
ROIC
70.94%
132.17%
223.19%
ROCE
32.89%
45.55%
74.84%
EV
Common stock shares outstanding
38,997
39,377
40,525
Price
2,909.00
-5.71%
3,085.00
-0.16%
3,090.00
-19.22%
Market cap
113,442,250
-6.62%
121,478,193
-2.99%
125,220,795
-19.52%
EV
51,029,250
165,370,193
157,078,795
EBITDA
52,054,000
67,432,000
92,450,000
EV/EBITDA
0.98
2.45
1.70
Interest
104,000
40,000
36,000
Interest/NOPBT
0.23%
0.07%
0.04%